BrainsWay Announces New Clinical Support Program for Physicians Treating Obsessive-Compulsive Disord
BrainsWay Announces New Clinical Support Program for Physicians Treating Obsessive-Compulsive Disorder: – “BrainsWay OCD Launchpad to...
top of page
News & Events
Mar 4, 2019
BrainsWay Expands Intellectual Property Position by Obtaining Rights to Multi-Channel Transcranial M
BrainsWay Expands Intellectual Property Position by Obtaining Rights to Multi-Channel Transcranial Magnetic Stimulation Patent Portfolio...
Feb 20, 2019
BrainsWay Expands its Deep TMS Commercial Footprint into Asia Pacific
Enters into an Agreement to Distribute its Deep Transcranial Magnetic Stimulation System in South Korea. JERUSALEM, February 20, 2019 –...
Feb 19, 2019
BrainsWay Receives FDA 510(k) Clearance for Use of its Next-Generation Stimulator for the Treatment
BrainsWay Receives FDA 510(k) Clearance for Use of its Next-Generation Stimulator for the Treatment of Obsessive Compulsive Disorder...
Jan 29, 2019
BrainsWay Receives PMDA Approval in Japan of Deep Transcranial Magnetic Stimulation System for Treat
BrainsWay Receives PMDA Approval in Japan of Deep Transcranial Magnetic Stimulation System for Treatment of Major Depressive Disorder...
Dec 10, 2018
BrainsWay Selected to Participate in FDA Innovation Challenge: Devices to Prevent and Treat Opioid U
BrainsWay Selected to Participate in FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder Company’s Deep...
Nov 13, 2018
BrainsWay Ltd. Q3 2018 results – conference call November 13, 2018
Press the link to hear the conference call
Nov 13, 2018
BrainsWay to Showcase FDA-Cleared Deep Transcranial Magnetic Stimulation System for the Treatment of
BrainsWay to Showcase FDA-Cleared Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-Compulsive Disorder at...
Oct 17, 2018
BrainsWay to Showcase Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-C
BrainsWay to Showcase Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-Compulsive Disorder at the 2018 Annual...
Oct 10, 2018
BrainsWay Announces First Shipments of Deep Transcranial Magnetic Stimulation Helmets for the Treatm
BrainsWay Announces First Shipments of Deep Transcranial Magnetic Stimulation Helmets for the Treatment of Obsessive-Compulsive Disorder...
Aug 27, 2018
BrainsWay Reports Financial Results for Second Quarter of 2018 and Provides Corporate Update
Second quarter revenues of $3.7 million represent a quarterly record and a 57% increase over second quarter 2017 Recently announced FDA...
Aug 19, 2018
BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive Comp
BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive Compulsive Disorder BrainsWay’s deep...
Jun 7, 2018
BrainsWay and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic
BrainsWay and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress Disorder Unique Biomarkers...
May 30, 2018
BrainsWay Reports Record Financial Results for First Quarter of 2018 and Provides Corporate Update
First quarter revenues of $3.6 million represent a quarterly record and a 68% increase over first quarter 2017 Increased market demand...
May 23, 2018
Achieve TMS Announces Grand Opening of New Location in Newton, Massachusetts
NEWTON, Mass., May 23, 2018 (GLOBE NEWSWIRE) — Achieve TMS, the largest U.S. provider of BrainsWay’s Deep Transcranial Magnetic...
May 6, 2018
BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transc...
BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transcranial Magnetic Stimulation (Deep TMS)...
Dec 12, 2017
BrainsWay Raises $8.5 Million From Leading Israeli Investors
Phoenix Group becomes 7% shareholder. financing strengthens BrainsWay’s balance sheet and provides strong support for continued growth...
Nov 20, 2017
BrainsWay Reports Record Quarterly Revenues in Third Quarter of 2017
ncreased market demand and new leasing model continue to generate significant sales growth Recently signed contracts increased total...
Oct 19, 2017
The stock in the spotlight: BrainsWay
Sponsor Editoriial Board “The transition to focusing on the leasing business model helps us continue increasing the revenues we receive...
Aug 23, 2017
BrainsWay Reports Continued Successful Implementation of its New Business Model in Second Quarter of
BrainsWay Reports Continued Successful Implementation of its New Business Model in Second Quarter of 2017 Backlog revenues due to future...
bottom of page